Latest Insider Transactions at Amicus Therapeutics, Inc. (FOLD)
This section provides a real-time view of insider transactions for Amicus Therapeutics, Inc. (FOLD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMICUS THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMICUS THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2022
|
Daphne Quimi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,396
-1.26%
|
$39,564
$9.0 P/Share
|
|
Jun 15
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
10,468
-1.12%
|
$83,744
$8.01 P/Share
|
|
Jun 09
2022
|
Lynn Dorsey Bleil |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+14.77%
|
-
|
|
Jun 09
2022
|
Michael Aaron Kelly |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+28.61%
|
-
|
|
Jun 09
2022
|
Margaret G Mcglynn |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+19.99%
|
-
|
|
Jun 09
2022
|
Michael Raab |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+20.41%
|
-
|
|
Jun 09
2022
|
Eiry Roberts |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+26.34%
|
-
|
|
Jun 09
2022
|
Glenn Sblendorio |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+15.01%
|
-
|
|
Jun 09
2022
|
Craig A Wheeler |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+22.44%
|
-
|
|
Jun 09
2022
|
Burke W Whitman |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+14.01%
|
-
|
|
Jun 03
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
11,346
-1.2%
|
$90,768
$8.0 P/Share
|
|
May 23
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
21,814
-2.26%
|
$174,512
$8.0 P/Share
|
|
May 02
2022
|
Michael Raab |
SELL
Open market or private sale
|
Direct |
15,000
-28.99%
|
$90,000
$6.99 P/Share
|
|
May 02
2022
|
Michael Raab |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+22.47%
|
$60,000
$4.79 P/Share
|
|
May 02
2022
|
Margaret G Mcglynn |
SELL
Open market or private sale
|
Direct |
15,000
-28.28%
|
$90,000
$6.99 P/Share
|
|
May 02
2022
|
Margaret G Mcglynn |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+22.05%
|
$60,000
$4.79 P/Share
|
|
Apr 19
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
8,254
-0.85%
|
$66,032
$8.01 P/Share
|
|
Apr 18
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,214
-0.23%
|
$17,712
$8.04 P/Share
|
|
Apr 07
2022
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
11,018
-3.51%
|
$99,162
$9.06 P/Share
|
|
Mar 18
2022
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,940
-1.84%
|
$109,400
$10.0 P/Share
|
|
Mar 18
2022
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,940
+1.8%
|
$32,820
$3.53 P/Share
|
|
Mar 15
2022
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
104,603
+13.17%
|
-
|
|
Mar 04
2022
|
Glenn Sblendorio |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+20.26%
|
$60,000
$4.79 P/Share
|
|
Jan 18
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
8,564
-0.87%
|
$85,640
$10.23 P/Share
|
|
Jan 14
2022
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
32,386
-5.25%
|
$323,860
$10.53 P/Share
|
|
Jan 14
2022
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
63,317
+9.3%
|
-
|
|
Jan 14
2022
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,843
-5.11%
|
$188,430
$10.53 P/Share
|
|
Jan 14
2022
|
Daphne Quimi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,840
+9.08%
|
-
|
|
Jan 14
2022
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
58,891
-5.64%
|
$588,910
$10.53 P/Share
|
|
Jan 14
2022
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
388,759
+16.82%
|
-
|
|
Jan 14
2022
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,898
-5.11%
|
$168,980
$10.53 P/Share
|
|
Jan 14
2022
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,143
+10.58%
|
-
|
|
Jan 14
2022
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,684
-5.3%
|
$126,840
$10.53 P/Share
|
|
Jan 14
2022
|
David Michael Clark Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
91,306
+17.02%
|
-
|
|
Jan 05
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
63,543
-8.84%
|
$762,516
$12.18 P/Share
|
|
Jan 04
2022
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,368
-1.31%
|
$88,416
$12.48 P/Share
|
|
Jan 04
2022
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,041
-1.2%
|
$48,492
$12.48 P/Share
|
|
Jan 04
2022
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,575
-1.21%
|
$42,900
$12.48 P/Share
|
|
Jan 04
2022
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
11,336
-1.55%
|
$136,032
$12.48 P/Share
|
|
Jan 04
2022
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,692
-1.78%
|
$32,304
$12.48 P/Share
|
|
Jan 03
2022
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
154,711
+21.6%
|
-
|
|
Jan 03
2022
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
5,470
-1.33%
|
$60,170
$11.86 P/Share
|
|
Jan 03
2022
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,470
+1.31%
|
$16,410
$3.53 P/Share
|
|
Jan 03
2022
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,984
-1.21%
|
$59,808
$12.11 P/Share
|
|
Jan 03
2022
|
Daphne Quimi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,136
+17.88%
|
-
|
|
Jan 03
2022
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,538
-0.58%
|
$18,456
$12.11 P/Share
|
|
Jan 03
2022
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,136
+19.85%
|
-
|
|
Jan 03
2022
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,970
-1.32%
|
$35,640
$12.11 P/Share
|
|
Jan 03
2022
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
40,069
-5.2%
|
$480,828
$12.11 P/Share
|
|
Jan 02
2022
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,946
-6.36%
|
$307,406
$11.55 P/Share
|